These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
137 related items for PubMed ID: 18444515
1. Fate of quinidine, a P-glycoprotein substrate, in the gastrointestinal tract after oral administration in rats. Mori N, Yokooji T, Murakami T. Pharmazie; 2008 Mar; 63(3):241-4. PubMed ID: 18444515 [Abstract] [Full Text] [Related]
2. Marked impact of P-glycoprotein on the absorption of TAK-427 in rats. Takeuchi T, Nonaka M, Yoshitomi S, Higuchi T, Ebihara T, Maeshiba Y, Kawase M, Asahi S. Biopharm Drug Dispos; 2008 Sep; 29(6):311-23. PubMed ID: 18651556 [Abstract] [Full Text] [Related]
3. Characterization of intestinal absorption of quinidine, a P-glycoprotein substrate, given as a powder in rats. Mori N, Iwamoto H, Yokooji T, Murakami T. Pharmazie; 2012 May; 67(5):384-8. PubMed ID: 22764568 [Abstract] [Full Text] [Related]
5. pH-dependent functional activity of P-glycoprotein in limiting intestinal absorption of protic drugs: kinetic analysis of quinidine efflux in situ. Varma MV, Panchagnula R. J Pharm Sci; 2005 Dec; 94(12):2632-43. PubMed ID: 16258992 [Abstract] [Full Text] [Related]
6. Study on absorption sites of quinidine and methotrexate in rat intestine. Murakami T, Yokooji T, Mori N. Pharmazie; 2010 Jun; 65(6):440-7. PubMed ID: 20614693 [Abstract] [Full Text] [Related]
7. Up-regulation of P-glycoprotein expression in small intestine under chronic serotonin-depleted conditions in rats. Hiraoka H, Kimura N, Furukawa Y, Ogawara K, Kimura T, Higaki K. J Pharmacol Exp Ther; 2005 Jan; 312(1):248-55. PubMed ID: 15466248 [Abstract] [Full Text] [Related]
8. Modest effect of impaired P-glycoprotein on the plasma concentrations of fexofenadine, quinidine, and loperamide following oral administration in collies. Kitamura Y, Koto H, Matsuura S, Kawabata T, Tsuchiya H, Kusuhara H, Tsujimoto H, Sugiyama Y. Drug Metab Dispos; 2008 May; 36(5):807-10. PubMed ID: 18299336 [Abstract] [Full Text] [Related]
9. Pharmacokinetics of baicalin in rats and its interactions with cyclosporin A, quinidine and SKF-525A: a microdialysis study. Tsai PL, Tsai TH. Planta Med; 2004 Nov; 70(11):1069-74. PubMed ID: 15549664 [Abstract] [Full Text] [Related]
11. Scaling of in vitro membrane permeability to predict P-glycoprotein-mediated drug absorption in vivo. Shirasaka Y, Masaoka Y, Kataoka M, Sakuma S, Yamashita S. Drug Metab Dispos; 2008 May; 36(5):916-22. PubMed ID: 18276834 [Abstract] [Full Text] [Related]
12. Effects of quercetin on the pharmacokinetics of Etoposide after oral or intravenous administration of etoposide in rats. Li X, Choi JS. Anticancer Res; 2009 Apr; 29(4):1411-5. PubMed ID: 19414395 [Abstract] [Full Text] [Related]
18. Effects of quinidine on antinociception and pharmacokinetics of morphine in rats. Okura T, Morita Y, Ito Y, Kagawa Y, Yamada S. J Pharm Pharmacol; 2009 May; 61(5):593-7. PubMed ID: 19405997 [Abstract] [Full Text] [Related]
20. The effects of quinidine and its chiral isolates on erg-1sm potassium current and correlation with gastrointestinal augmentation. Cvetanovic I, Lin C, Ranade V, Keshavarzian A, Somberg J. Am J Ther; 2007 May; 14(3):269-76. PubMed ID: 17515703 [Abstract] [Full Text] [Related] Page: [Next] [New Search]